The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity.BDB
Astex
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.BDB
Astex
Rapid Evolution of 6-Phenylpurine Inhibitors of Protein Kinase B through Structure-Based Design.BDB
Astex
Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery.BDB
Astex
Application of fragment screening by X-ray crystallography to beta-secretase.BDB
Astex
Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.BDB
Astex
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.BDB
Astex
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.BDB
Astex
Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors.BDB
Astex